1. Home
  2. SMID vs VTYX Comparison

SMID vs VTYX Comparison

Compare SMID & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMID
  • VTYX
  • Stock Information
  • Founded
  • SMID 1960
  • VTYX 2018
  • Country
  • SMID United States
  • VTYX United States
  • Employees
  • SMID N/A
  • VTYX N/A
  • Industry
  • SMID Building Materials
  • VTYX Medicinal Chemicals and Botanical Products
  • Sector
  • SMID Industrials
  • VTYX Health Care
  • Exchange
  • SMID Nasdaq
  • VTYX Nasdaq
  • Market Cap
  • SMID 167.5M
  • VTYX 154.9M
  • IPO Year
  • SMID 1995
  • VTYX 2021
  • Fundamental
  • Price
  • SMID $33.99
  • VTYX $1.39
  • Analyst Decision
  • SMID
  • VTYX Buy
  • Analyst Count
  • SMID 0
  • VTYX 4
  • Target Price
  • SMID N/A
  • VTYX $11.33
  • AVG Volume (30 Days)
  • SMID 7.2K
  • VTYX 941.6K
  • Earning Date
  • SMID 06-10-2025
  • VTYX 05-08-2025
  • Dividend Yield
  • SMID N/A
  • VTYX N/A
  • EPS Growth
  • SMID 1025.92
  • VTYX N/A
  • EPS
  • SMID 1.22
  • VTYX N/A
  • Revenue
  • SMID $76,366,000.00
  • VTYX N/A
  • Revenue This Year
  • SMID N/A
  • VTYX $59.59
  • Revenue Next Year
  • SMID N/A
  • VTYX $69.43
  • P/E Ratio
  • SMID $26.64
  • VTYX N/A
  • Revenue Growth
  • SMID 32.40
  • VTYX N/A
  • 52 Week Low
  • SMID $25.03
  • VTYX $0.78
  • 52 Week High
  • SMID $51.96
  • VTYX $5.66
  • Technical
  • Relative Strength Index (RSI)
  • SMID 60.56
  • VTYX 51.70
  • Support Level
  • SMID $31.49
  • VTYX $1.11
  • Resistance Level
  • SMID $33.49
  • VTYX $1.26
  • Average True Range (ATR)
  • SMID 1.86
  • VTYX 0.12
  • MACD
  • SMID 0.45
  • VTYX -0.00
  • Stochastic Oscillator
  • SMID 100.00
  • VTYX 45.35

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Share on Social Networks: